Funds and ETFs Shanghai Junshi Biosciences Co., Ltd. Shanghai S.E.

Equities

688180

CNE1000041Z1

Pharmaceuticals

End-of-day quote Shanghai S.E. 23:00:00 12/06/2024 BST 5-day change 1st Jan Change
30.4 CNY +0.40% Intraday chart for Shanghai Junshi Biosciences Co., Ltd. +5.92% -27.32%
Shanghai Junshi Biosciences Co Ltd is a China-based company mainly engaged in innovation-driven biopharmaceutical business. The Company's main businesses are the discovery, clinical research and development of innovative drugs. The Company's main products include teriprizumab injection, Etesevimab, adalimumab injection and other drugs, which are used to treat malignant tumors, autoimmune system diseases, chronic metabolic diseases, nervous system diseases and infectious diseases . The Company is also engaged in the clinical research and development of recombinant humanized anti-PCSK9 monoclonal antibody injection and other drugs. The Company provides its products for domestic and overseas markets.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
11.29 CNY
Average target price
21.44 CNY
Spread / Average Target
+89.92%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 1877 Stock
  4. 688180 Stock
  5. Funds and ETFs Shanghai Junshi Biosciences Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW